A pathogenic mutation in ANAPC1 leads to a genetic disorder, Rothmund–Thomson syndrome (OMIM number 618625), which mainly affects the skin but also the bones and has also recently been linked to an increased risk of osteosarcoma [24]. The gene discussed is ANAPC1; the disease is osteosarcoma.